← Back to Clinical Trials
Recruiting NCT05678543

NCT05678543 Danish Diabetes Birth Registry 2

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05678543
Status Recruiting
Phase
Sponsor Odense University Hospital
Condition Pregnancy in Diabetic
Study Type OBSERVATIONAL
Enrollment 2,500 participants
Start Date 2023-01-01
Primary Completion 2027-12-31

Trial Parameters

Condition Pregnancy in Diabetic
Sponsor Odense University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-01-01
Completion 2027-12-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Pregnancies in women with pre-existing diabetes are considered "high risk" pregnancies, poses daily clinical challenges and in terms of research - a number of unanswered questions. Therefore, the investigators wish to establish a nationwide cohort of pregnancies complicated by pre-existing diabetes - the Danish Diabetes Birth Registry (DDBR2) The DDBR2 registry comprises all types of pre-existing diabetes including T1D, T2D and other types (as MODY), generating a nationwide cohort of mother/partner/children trios with accessible registry-, clinical data and biological biobank samples. This will enable the investigators to use data longitudinally to examine short- and long-term outcomes of pregnancies in women with diabetes.

Eligibility Criteria

Inclusion Criteria: * Women, age ≥ 18 years * Type 1 diabetes, type 2 diabetes or other types of pre-existing diabetes (e.g., maturity onset diabetes of the young (MODY)) * Partners of women fulfilling these inclusion criteria, age ≥ 18 years * Offspring of women fulfilling these inclusion criteria Exclusion Criteria: * No proficiency in Danish or English to understand oral and written information

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology